Re:Pfizer's oral Covid-19 antiviral cuts hospitalization, de...
by acdha on Friday November 05, 2021 @10:28AM
(#29119751)
The study was for patients “who were at high risk of progressing to severe illness”, where the hospitalization/death rate was 6.7% without it and 1% with. You probably wouldn’t give it out to everyone but that’s the kind of risk decision doctors make routinely.
[ Parent
| on HN ]
Re:Pfizer's oral Covid-19 antiviral cuts hospitalization, de...
by fspeech on Friday November 05, 2021 @10:34AM
(#29119838)
The actual death rate for the trial cohort is close to 2%:
Pfizer said 0.8 percent of patients who got the drug combination within three days were hospitalized within four weeks — three out of 389 patients — compared to 7 percent of patients who got placebos, or 27 out of 385. And seven of those who got placebos died, Pfizer said. No one who got the treatment died within a month.
https://nymag.com/intelligencer/2021/11/pfizers-new-covid-pi...